{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:33:14Z","timestamp":1791419594260,"version":"4.3.3"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.numecd.2021.10.015","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:39:20Z","timestamp":1635381560000},"page":"309-317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Lipoprotein(a) and aortic valve stenosis: A casual or causal association?"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6371-6327","authenticated-orcid":false,"given":"Gloria","family":"Santangelo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3247-3203","authenticated-orcid":false,"given":"Andrea","family":"Faggiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Carugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Giammanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7997-6908","authenticated-orcid":false,"given":"Pompilio","family":"Faggiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.numecd.2021.10.015_bib1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nrcardio.2010.202","article-title":"Epidemiology of valvular heart disease in the adult","volume":"8","author":"Iung","year":"2011","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"10.1016\/j.numecd.2021.10.015_bib2","first-page":"e35","article-title":"ACC\/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto","year":"2020","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.numecd.2021.10.015_bib3","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/0735-1097(93)90249-Z","article-title":"Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample","volume":"21","author":"Lindroos","year":"1993","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 1","key":"10.1016\/j.numecd.2021.10.015_bib4","first-page":"15","article-title":"Diagnosis and management of valvular aortic stenosis","volume":"8","author":"Czarny","year":"2014","journal-title":"Clin Med Insights Cardiol"},{"issue":"5","key":"10.1016\/j.numecd.2021.10.015_bib5","doi-asserted-by":"crossref","first-page":"8681","DOI":"10.1161\/CIRCINTERVENTIONS.119.008681","article-title":"Relative costs of surgical and transcatheter aortic valve replacement and medical therapy","volume":"13","author":"Goldsweig","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"issue":"28","key":"10.1016\/j.numecd.2021.10.015_bib6","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1093\/eurheartj\/ehx653","article-title":"Calcific aortic valve stenosis: hard disease in the heart: a biomolecular approach towards diagnosis and treatment","volume":"39","author":"Peeters","year":"2018","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.numecd.2021.10.015_bib7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41569-018-0153-2","article-title":"Oxidized phospholipids as a unifying theory for lipoprotein(a) and cardiovascular disease","volume":"16","author":"Boffa","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.numecd.2021.10.015_bib8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1699-0463.1963.tb01808.x","article-title":"New serum type system in man--the lp system","volume":"59","author":"Berg","year":"1963","journal-title":"Acta Pathol Microbiol Scand"},{"issue":"2","key":"10.1016\/j.numecd.2021.10.015_bib9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/joim.12335","article-title":"Lipoprotein(a) levels are associated with aortic valve calcification in asymptomatic patients with familial hypercholesterolaemia","volume":"278","author":"Vongpromek","year":"2015","journal-title":"J Intern Med"},{"issue":"3","key":"10.1016\/j.numecd.2021.10.015_bib10","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jacl.2018.02.014","article-title":"Relationship between ``LDL-C\u2019\u2019, estimated true LDL-C, apolipoprotein B-100, and PCSK9 levels following lipoprotein(a) lowering with an antisense oligonucleotide","volume":"12","author":"Viney","year":"2018","journal-title":"J Clin Lipidol"},{"issue":"10","key":"10.1016\/j.numecd.2021.10.015_bib11","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1139\/o86-133","article-title":"Isolation and partial characterization of apolipoprotein (a) from human lipoprotein (a)","volume":"64","author":"Seman","year":"1986","journal-title":"Biochem Cell Biol"},{"issue":"20","key":"10.1016\/j.numecd.2021.10.015_bib12","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1093\/eurheartj\/ehx033","article-title":"Lipoprotein(a): the revenant","volume":"38","author":"Gencer","year":"2017","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.numecd.2021.10.015_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2019","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.numecd.2021.10.015_bib14","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0002-9149(99)80263-X","article-title":"Correlation between lipoprotein(a) and aortic valve sclerosis assessed by echocardiography (the JMS Cardiac Echo and Cohort Study)","volume":"76","author":"Gotoh","year":"1995","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.numecd.2021.10.015_bib15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1109034","article-title":"Genetic associations with valvular calcification and aortic stenosis","volume":"368","author":"Thanassoulis","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.numecd.2021.10.015_bib16","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCGENETICS.113.000400","article-title":"Lipoprotein(a) levels, genotype, and incident aortic valve stenosis: a prospective Mendelian randomization study and replication in a case-control cohort","volume":"7","author":"Arsenault","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"issue":"5","key":"10.1016\/j.numecd.2021.10.015_bib17","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jacc.2013.09.038","article-title":"Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population","volume":"63","author":"Kamstrup","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2021.10.015_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.atherosclerosis.2018.11.040","article-title":"Lipoprotein(a) as a risk factor for calcific aortic valvulopathy in heterozygous familial hypercholesterolemia","volume":"281","author":"Vuorio","year":"2019","journal-title":"Atherosclerosis"},{"issue":"16","key":"10.1016\/j.numecd.2021.10.015_bib19","doi-asserted-by":"crossref","first-page":"13020","DOI":"10.1161\/JAHA.119.013020","article-title":"apoB\/apoA-I ratio and lp(a) associations with aortic valve stenosis incidence: insights from the EPIC-norfolk prospective population study","volume":"8","author":"Zheng","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"10.1016\/j.numecd.2021.10.015_bib20","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.jacc.2015.07.020","article-title":"Oxidized phospholipids, lipoprotein(a), and progression of calcific aortic valve stenosis","volume":"66","author":"Capoulade","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.numecd.2021.10.015_bib21","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.jacc.2019.01.070","article-title":"Lipoprotein(a) and oxidized phospholipids promote valve calcification in patients with aortic stenosis","volume":"73","author":"Zheng","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.numecd.2021.10.015_bib22","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1002\/jcp.26050","article-title":"Lipoprotein(a): a missing culprit in the management of athero-thrombosis?","volume":"233","author":"Ferretti","year":"2018","journal-title":"J Cell Physiol"},{"issue":"6144","key":"10.1016\/j.numecd.2021.10.015_bib23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/330113a0","article-title":"Plasma lipoproteins: teaching old dogmas new tricks","volume":"330","author":"Brown","year":"1987","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.numecd.2021.10.015_bib24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pcad.2020.04.004","article-title":"What do we know about the role of lipoprotein(a) in atherogenesis 57 years after its discovery?","volume":"63","author":"Cybulska","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"issue":"10","key":"10.1016\/j.numecd.2021.10.015_bib25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11883-019-0803-9","article-title":"Looking at lp(a) and related cardiovascular risk: from scientific evidence and clinical practice","volume":"21","author":"Stulnig","year":"2019","journal-title":"Curr Atherosclerosis Rep"},{"issue":"12","key":"10.1016\/j.numecd.2021.10.015_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/biom9120760","article-title":"Lipoprotein(a) as orchestrator of calcific aortic valve stenosis","volume":"9","author":"Schnitzler","year":"2019","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/j.numecd.2021.10.015_bib27","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1359\/jbmr.2003.18.10.1842","article-title":"BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop","volume":"18","author":"Rawadi","year":"2003","journal-title":"J Bone Miner Res"},{"issue":"8","key":"10.1016\/j.numecd.2021.10.015_bib28","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/CIRCULATIONAHA.116.020838","article-title":"Oxidized phospholipids on lipoprotein(a) elicit arterial wall inflammation and an inflammatory monocyte response in humans","volume":"134","author":"van der Valk","year":"2016","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.numecd.2021.10.015_bib29","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/clc.4960141210","article-title":"Development and progression of aortic valve stenosis: atherosclerosis risk factors--a causal relationship? A clinical morphologic study","volume":"14","author":"Mohler","year":"1991","journal-title":"Clin Cardiol"},{"issue":"3","key":"10.1016\/j.numecd.2021.10.015_bib30","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0735-1097(96)00563-3","article-title":"Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study","volume":"29","author":"Stewart","year":"1997","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.numecd.2021.10.015_bib31","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/0002-9149(87)91144-1","article-title":"Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients","volume":"59","author":"Aronow","year":"1987","journal-title":"Am J Cardiol"},{"issue":"17","key":"10.1016\/j.numecd.2021.10.015_bib32","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1161\/CIRCULATIONAHA.105.598086","article-title":"Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the Multi-Ethnic Study of Atherosclerosis","volume":"113","author":"Katz","year":"2006","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.numecd.2021.10.015_bib33","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.jacc.2005.12.073","article-title":"Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis","volume":"47","author":"Briand","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.numecd.2021.10.015_bib34","first-page":"133","article-title":"Association of serum lipoprotein(a) level with the severity and prognosis of calcific aortic valve stenosis: a Chinese cohort study","volume":"17","author":"Liu","year":"2020","journal-title":"J Geriatr Cardiol"},{"key":"10.1016\/j.numecd.2021.10.015_bib35","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2021-319044","article-title":"Lipoprotein(a) is robustly associated with aortic valve calcium","author":"Kaiser","year":"2021","journal-title":"Heart"},{"issue":"9","key":"10.1016\/j.numecd.2021.10.015_bib36","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJM200008313430903","article-title":"Predictors of outcome in severe, asymptomatic aortic stenosis","volume":"343","author":"Rosenhek","year":"2000","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.numecd.2021.10.015_bib37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ehj.2003.12.002","article-title":"Mild and moderate aortic stenosis. Natural history and risk stratification by echocardiography","volume":"25","author":"Rosenhek","year":"2004","journal-title":"Eur Heart J"},{"issue":"36","key":"10.1016\/j.numecd.2021.10.015_bib38","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.numecd.2021.10.015_bib39","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1161\/STROKEAHA.116.015200","article-title":"Aortic valve calcification and risk of stroke: the Rotterdam study","volume":"47","author":"Bos","year":"2016","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.numecd.2021.10.015_bib40","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0009-9260(03)00184-3","article-title":"Aortic valve calcification on computed tomography predicts the severity of aortic stenosis","volume":"58","author":"Cowell","year":"2003","journal-title":"Clin Radiol"},{"issue":"2","key":"10.1016\/j.numecd.2021.10.015_bib41","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.atherosclerosis.2014.11.026","article-title":"Early aortic valve inflammation precedes calcification: a longitudinal FDG-PET\/CT study","volume":"238","author":"Abdelbaky","year":"2015","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.numecd.2021.10.015_bib42","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jacc.2015.06.1325","article-title":"Valvular (18)F-fluoride and (18)F-fluorodeoxyglucose uptake predict disease progression and clinical outcome in patients with aortic stenosis","volume":"66","author":"Jenkins","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.numecd.2021.10.015_bib43","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.jacc.2011.12.037","article-title":"Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology","volume":"59","author":"Dweck","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.numecd.2021.10.015_bib44","doi-asserted-by":"crossref","first-page":"862","DOI":"10.2967\/jnumed.110.076471","article-title":"Feasibility of 18F-sodium fluoride PET\/CT for imaging of atherosclerotic plaque","volume":"51","author":"Derlin","year":"2010","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.numecd.2021.10.015_bib45","doi-asserted-by":"crossref","first-page":"362","DOI":"10.2967\/jnumed.110.081208","article-title":"In\u00a0vivo imaging of mineral deposition in carotid plaque using 18F-sodium fluoride PET\/CT: correlation with atherogenic risk factors","volume":"52","author":"Derlin","year":"2011","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.numecd.2021.10.015_bib46","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1161\/CIRCIMAGING.113.001508","article-title":"18F-sodium fluoride uptake is a marker of active calcification and disease progression in patients with aortic stenosis","volume":"7","author":"Dweck","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.numecd.2021.10.015_bib47","doi-asserted-by":"crossref","first-page":"7495","DOI":"10.1038\/ncomms8495","article-title":"Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography","volume":"6","author":"Irkle","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.numecd.2021.10.015_bib48","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.051052","article-title":"Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis","volume":"125","author":"Dweck","year":"2012","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.numecd.2021.10.015_bib49","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1001\/jamacardio.2018.3798","article-title":"Association of mild to moderate aortic valve stenosis progression with higher lipoprotein(a) and oxidized phospholipid levels: secondary analysis of a randomized clinical trial","volume":"3","author":"Capoulade","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"13","key":"10.1016\/j.numecd.2021.10.015_bib50","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis","volume":"359","author":"Rossebo","year":"2008","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.numecd.2021.10.015_bib51","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMoa043876","article-title":"A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis","volume":"352","author":"Cowell","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.numecd.2021.10.015_bib52","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/CIRCULATIONAHA.109.900027","article-title":"Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial","volume":"121","author":"Chan","year":"2010","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.numecd.2021.10.015_bib53","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/CIRCULATIONAHA.118.037184","article-title":"Lipoprotein(a), PCSK9 inhibition, and cardiovascular risk","volume":"139","author":"O'Donoghue","year":"2019","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.numecd.2021.10.015_bib54","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1210\/jc.2016-1206","article-title":"PCSK9 R46L loss-of-function mutation reduces lipoprotein(a), LDL cholesterol, and risk of aortic valve stenosis","volume":"101","author":"Langsted","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.numecd.2021.10.015_bib55","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jacbts.2020.05.004","article-title":"Genetic and in\u00a0vitro inhibition of PCSK9 and calcific aortic valve stenosis","volume":"5","author":"Perrot","year":"2020","journal-title":"JACC Basic Transl Sci"},{"issue":"6","key":"10.1016\/j.numecd.2021.10.015_bib56","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/jamacardio.2020.0728","article-title":"An exploratory analysis of proprotein convertase subtilisin\/kexin type 9 inhibition and aortic stenosis in the FOURIER trial","volume":"5","author":"Bergmark","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.numecd.2021.10.015_bib58","series-title":"Assessing the impact of lipoprotein (a) lowering with TQJ230 on major cardiovascular events in patients with CVD\u2014full text view\u2014ClinicalTrials.gov [Internet]","year":"2020"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475321005135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475321005135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:19:22Z","timestamp":1760545162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475321005135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0939475321005135"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2021.10.015","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipoprotein(a) and aortic valve stenosis: A casual or causal association?","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2021.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}